This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Jonathon Marc Goldhill: Innovator in Inflammatory Disease Treatment
Introduction
Jonathon Marc Goldhill is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory diseases. His work has led to the development of innovative solutions that address critical health issues.
Latest Patents
Goldhill holds a patent for the "Use of mizolastine for treating inflammatory diseases associated with." This patent highlights his commitment to advancing medical treatments and improving patient outcomes. He has successfully navigated the complexities of the patent process, securing his intellectual property rights.
Career Highlights
Goldhill is currently employed at Sanofi-Synthelabo, a leading global healthcare company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research. His dedication to innovation is evident in his work and the impact it has on the medical community.
Collaborations
Throughout his career, Goldhill has worked alongside talented colleagues, including Sonia Arbilla and Luc Even. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of excellence in research.
Conclusion
Jonathon Marc Goldhill is a distinguished inventor whose work in treating inflammatory diseases has made a significant impact in the medical field. His patent and contributions at Sanofi-Synthelabo exemplify his dedication to innovation and improving healthcare solutions.